Biomx Inc. (PHGE), a key player in the Healthcare sector and Biotechnology service category, has been making waves in the market with its recent performance. The company's stock, which has a 52-week high of $0.78, has been showing a promising trend, with a 200-day moving average of $0.3193. Despite a negative EBITDA of $25M and operating income loss of $27.2M, the company maintains a strong working capital of $28.94M and net invested capital of $35.9M. The company's current valuation and enterprise value stand at $3.6M, with net receivables of $567K. However, it's worth noting that Biomx has a high short ratio of 0.12, with short percent of 0.0003, indicating a potential risk. With an analyst target price estimated value of $6.5 and the highest estimated target price reaching up to $7, the question remains - is Biomx Inc. a solid investment choice? Let's delve deeper into its technical and fundamental aspects to find out. Despite somewhat unstable technical and fundamental indicators, Biomx may be nearing a crucial reversion point that could propel its shares even higher in September 2023. Will shareholders maintain their positions, or should we anticipate a sell-off?
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Biomx income statement, its balance sheet, and the statement of cash flows. Potential Biomx investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biomx investors may use each financial statement separately, they are all related. The changes in Biomx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Biomx
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Biomx performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Biomx shares is the value that is considered the true value of the share. If
the intrinsic value of Biomx is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Biomx. Please read more on our
fundamental analysis page.
Watch out for price decline
Please consider monitoring Biomx on a daily basis if you are holding a position in it. Biomx is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Biomx stock to be traded above the $1 level to remain listed. If Biomx stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How effective is Biomx in utilizing its assets?
Biomx Inc reports assets on its Balance Sheet. It represents the amount of Biomx resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, Biomx aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Biotechnology space. To get a better handle on how balance sheet or income statements item affect Biomx volatility, please check the breakdown of all its
fundamentals.
Are Biomx Earnings Expected to grow?
The
future earnings power of Biomx involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Biomx factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Biomx
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Biomx
expected earnings.
Biomx Gross Profit
Biomx Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Biomx previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Biomx Gross Profit growth over the last 10 years. Please check Biomx's
gross profit and other
fundamental indicators for more details.
What is driving Biomx Investor Appetite?
Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Biomx is not uncomon. There are few distinct groups of Biomx stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Biomx is distributed among investors.
Ownership Allocation
Biomx holds a total of fourty-five million nine hundred seventy-nine thousand seven hundred
outstanding shares. Biomx Inc retains significant amount of outstanding shares owned by
insiders. An
insider is usually defined as a CEO, other corporate executive, director, or
institutional investors. class="underlinedLink" href="/invest/ratio/PHGE/Shares-Owned-by-Institutions">institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
| Retail Investors62.87% | Insiders20.34% | Institutions16.79% |
| Retail Investors | 62.87 |
| Insiders | 20.34 |
| Institutions | 16.79 |
Asset Utilization
One of the ways to look at asset utilization of Biomx is to check how much profit was generated for every dollar of assets it reports. Biomx Inc shows a negative utilization of assets of -0.29 percent, losing $0.00291 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biomx Inc shows how discouraging it operates for each dollar spent on its assets.
| Current Assets | 48.08 Million | 81.54 |
| Assets Non Current | 9.21 Million | 15.62 |
| Goodwill | 1.68 Million | 2.85 |
Biomx Inc. (PHGE), a player in the healthcare and biotechnology sector, has recently seen a surge in its stock price. The company's current ratio stands at a robust
7.44X, indicating a strong liquidity position. However, the company has a substantial total debt of
$19.36M, comprising both short and long term debt. On the brighter side, the company has a healthy net working capital of $28.9M and a significant cash per share ratio of 1.53X. Nevertheless, the company's
financial health is not without concerns. It reported a net interest income loss of $1.6M and an earnings per share loss of $1.01. The total operating expenses stood at a hefty $27.2M, and the company also reported a change in working capital of -$4.4M. From a risk perspective, the company has a beta of 1.31, indicating higher volatility compared to the market. The risk-adjusted performance stands at 0.0976, and the value at risk is -9.09. The company's shares are primarily held by institutions, with 16.79% of shares owned by them. In conclusion, while Biomx Inc. has a solid liquidity position and a significant institutional ownership, the company's high debt and negative income raise concerns. Investors should approach this stock with caution, considering both its potential rewards and risks.
Our take on Biomx small dip
Biomx Inc. has recently demonstrated a significant decrease in kurtosis, dropping to 2.9. This statistical measure often signals a potential decline in volatility, suggesting that the stock's price fluctuations may become less severe. While some investors may perceive this as a sign of stability, others might see it as a lack of opportunity for substantial gains. Consequently, our recommendation for Biomx Inc. is to maintain your current position and closely monitor the stock for any shifts in
market sentiment or company fundamentals. Biomx Inc. is exhibiting above-average volatility over the chosen time horizon. Investors should independently scrutinize Biomx Inc. to ensure that their intended
market timing strategies align with their expectations about Biomx's volatility. Biomx Inc. is a potential penny stock.
While Biomx may indeed be a viable investment instrument, many penny stocks are speculative and subject to artificial price inflation. We urge investors to be aware of signals such as email spam, message board hype, claims of breakthroughs, volume upswings, sudden news releases, unreported promotions, or demotions released before SEC filings. It is also advisable to check the biographies and work histories of current and past company officers before investing in high volatility instruments, penny stocks, or equities with a microcap classification. It is possible to profit from the Biomx instrument if you time your entry and exit perfectly. However, keep in mind that penny stocks that have been subject to artificial hype are usually unable to sustain their increased share price for more than a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance supported by solid fundamentals. In conclusion, if you're doubtful about investing in Biomx Inc, it's important to consider the strong buy recommendations from
2 analysts, the valuation real value of
1.93, and the analyst target price estimated value of 6.5. The valuation market value of 0.42 and the valuation hype value of 0.44 also provide insight into the company's potential. While the analyst's highest estimated target price is 7, the lowest is 6, indicating a relatively stable and positive outlook. Therefore, based on these data points, Biomx Inc presents a promising investment opportunity. .
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Aina Ster is a Member of Macroaxis Editorial Board. Aina delivers weekly perspective on ongoing market and economic trends, analysis and tips from predictive analysis to forecasting across various financial instruments.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of Biomx Inc. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]